Searching the library

To search the library, click the blue search button below.

You are here

Vesicant Reference Library

Found 30 results
Author Title Type [ Year(Asc)]
Filters: Author is Kiser, R.C.  [Clear All Filters]
2008
Reid F.M., Kiser R.C., Hart W.E., McGuinness E.E., Mann J., Graham J.S.  2008.  Steroid efficacy applied to two depths of dermal injuries induced by sulfur mustard or liquid bromine. Proceedings of the U.S. Army Medical Defense Bioscience Review. 1, A135:168.
Reid F.M., Kiser R.C., Hart W.E., McGuinness E.E., Mann J., Graham J.S.  2008.  A sulfur mustard and thermal superficial dermal injury pig model. Proceedings of the U.S. Army Medical Defense Bioscience Review. 1, A136:169.
2005
Dillman, III J.F, Dorsch L.M., Hege A.I., Sylvester A.J., Phillips C.S., Kiser R.C., Choi Y.W., Sabourin C.L..  2005.  Correlating gene expression profiles with therapeutic efficacy of potential vesicant medical countermeasures. Proceedings of the 44th Annual Meeting of the Society of Toxicology. :774.
Smith W.J., Babin M.C., Kiser R.C., Casillas R.P..  2005.  Development of medical countermeasures to sulfur mustard vesication. Pentagon Reports. :6.
Moore D.M., Kiser R.C., Niemuth N.A., Biddle B.M., Babin M.C., Koplovitz I., Smith W.J..  2005.  Evaluation of the toxicity of medical countermeasures for sulfur mustard. Proceedings of the 44th Annual Meeting of the Society of Toxicology. :2201.
Moore D.M., Kiser R.C., Niemuth N.A., Biddle B.M., Babin M.C., Koplovitz I, Smith W.J..  2005.  Evaluation of the toxicity of medical countermeasures for sulfur mustard. Toxicological Sciences. 84:451.
Gerecke D.R., Bhatt P., Chang Y., Sabourin C.L., Rudge, Jr T.L., Kiser R.C., Casbohm S.L., Gordon M.K., Riley D.J., Shakarjian M.P. et al..  2005.  The matrix metalloproteinase inhibitor SM 1489 reduces MMP-9 activity after sulfur mustard exposure in vivo. Proceedings of the 44th Annual Meeting of the Society of Toxicology. :780.
Kiser R.C., Moore D.M., Niemuth N.A., Biddle B.M., Babin M.C., Casillas R.P., Koplovitz I., Smith W.J.  2005.  Mouse ear vesicant model (MEVM) evaluation of treatment combinations against topical sulfur mustard challenge. Proceedings of the 44th Annual Meeting of the Society of Toxicology. 84:451.
2004
Kiser R.C., Moore D.M., Niemuth N.A., Biddle B.M., Babin M.C., Casillas R.P., Smith W.J., Koplovitz I.  2004.  Combination treatments against cutaneous sulfur mustard exposure in the mouse ear vesicant model (MEVM). Proceedings of the U.S. Army Medical Defense Bioscience Review. 216:1-1.
Sabourin C.L.K., Choi Y.W., Stonerock M.K., Waugh J.D., Kiser R.C., Danne M.M., Buxton K.L., Casillas R.P., Babin M.C., Schlager J.J..  2004.  Expression profiling of sulfur mustard exposure in murine skin: chemokines, cytokines, and growth factors. Toxicogenomics and Proteomics. 356:109-116.
Rogers J.F., Choi Y.W., Kiser R.C., Casillas R.P., Babin M.C., Schlager J.J., Sabourin C.L..  2004.  Gene expression in mice exposed to low and high levels of sulfur mustard. Proceedings of the U.S. Army Medical Defense Bioscience Review. 229:1-1.
Rogers J.V., Choi Y.W., Kiser R.C., Casillas R.P., Babin M.C., Schlager J.J., Sabourin C.L..  2004.  Gene expression in mice exposed to low and high levels of sulfur mustard. Proceedings of the 43rd Annual meeting of the Society of Toxicology. :1733.
Dillman, III J.F, Dorsch L.M., Hege A.I., Phillips C.S., Silvester A.J., Kiser R.C., Choi Y.W., Sabourin C.L..  2004.  Genomic analysis of the mechanism of action of potential vesicant countermeasures. Proceedings of the U.S. Army Medical Defense Bioscience Review. 209:1-9.
Dillman, III J.F, Dorsch L.M., Hege A.I., Phillips C.S., Choi Y.W., Kiser R.C., Sabourin C.L..  2004.  Genomic analysis of the mechanism of action of potential vesicant countermeasures. Proceedings of the 43rd Annual Meeting of the Society of Toxicology. :1890.
Gerecke D.R., Sabourin C.L.K., Bhatt P., Rudge, Jr T.L., Casillas R.P., Kiser R.C., Casbohm S.L., Riley D.J., Ohman-Stickland P., Ajibade D.V. et al..  2004.  Laminin 5 and gelatinase alterations in mouse skin following sulfur mustard (SM) exposure. Proceedings of the U.S. Army Medical Defense Bioscience Review. 211:1-12.
Gerecke D.R., Bhatt P., Sabourin C.L., Rudge T.L., Casillas R.P., Kiser R.C., Casbohm S.L., Gordon M.K., Riley D.J., Shakarjian M.P..  2004.  Sulfur mustard alters laminin 5 and gelatinase MNRA levels and increases gelatinase activity in a mouse ear vesicant model. Proceedings of the 43rd Annual Meeting of the Society of Toxicology. :1888.
Sabourin C.L., Rogers J.V., Y.W. C., Kiser R.C., Casillas R.P., Babin M.C., Schlager J.J..  2004.  Time- and dose-dependent analysis of gene expression in sulfur mustard-exposed mice. Proceedings of the U.S. Army Medical Defense Bioscience Review. 231:1-1.
Sabourin C.L., Rogers J.V., Choi Y.W., Kiser R.C., Casillas R.P., Babin M.C., Schlager J.J..  2004.  Time- and dose-dependent analysis of gene expresssion in sulfur mustard-exposed mice. Proceedings of the 43rd Annual Meeting of the Society of Toxicology. :1891.
Kiser R.C., Moore D.M., Niemuth N.A., Biddle B.M., Babin M.C., Casillas R.P., Smith W.J., Koplovitz I..  2004.  Toxicity of candidate antivesicant compounds. Proceedings of the U.S. Army Medical Defense Bioscience Review. 217:1-1.
2001
Smith W.J., Babin M.C., Kiser R.C., Casillas R.P..  2001.  Development of medical countermeasures to sulfur mustard vesication. Proceedings of the 2001 Scientific Conference on Chemical and Biological Defense Research.

Pages

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer